Intermedical Care and Lab Hospital Public Company Limited

As of June 30, 2026, Intermedical Care and Lab Hospital Public Company Limited NVDR carries a market capitalization of 720.49M, placing it among publicly traded companies globally. Its enterprise value stands at 1.82B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Intermedical Care and Lab Hospital Public Company Limited NVDR's next confirmed earnings release is scheduled for November 17, 2026.

As of June 30, 2026, Intermedical Care and Lab Hospital Public Company Limited NVDR has 237.00M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.89, and the price-to-book ratio stands at 1.21.

As of June 30, 2026, Intermedical Care and Lab Hospital Public Company Limited NVDR trades at an EV/EBITDA multiple of 28.06 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 2.24 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 174.89 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 1.82B versus a market cap of 720.49M, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Intermedical Care and Lab Hospital Public Company Limited NVDR maintains a current ratio of 0.45, meaning it holds 0.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 155.66, indicating elevated leverage, while an interest coverage ratio of 1.12 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Intermedical Care and Lab Hospital Public Company Limited NVDR posted a negative return on equity (ROE) of -10.01, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -3.19, reflecting losses generated across the asset base. The company generates approximately 2.31M in revenue per employee across its workforce of 351.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 22.47 indicates how many times Intermedical Care and Lab Hospital Public Company Limited NVDR sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Intermedical Care and Lab Hospital Public Company Limited NVDR recorded 26.50M in income tax expense. The company reported a pretax loss of -46.93M and -66.40M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 22, 2026, Intermedical Care and Lab Hospital Public Company Limited NVDR's stock has declined approximately 18.78% over the past 52 weeks. The 50-day moving average sits at 3.41, while the 200-day moving average is 3.11.

Over the twelve months ended June 30, 2026, Intermedical Care and Lab Hospital Public Company Limited NVDR generated 811.55M in revenue and converted that into -66.40M in net income, yielding earnings per share of -0.31. EBITDA reached 64.81M, while operating income came in at 10.40M.

As of June 30, 2026, Intermedical Care and Lab Hospital Public Company Limited NVDR holds 7.50M in cash and equivalents against 1.04B in total debt, resulting in a net debt position of 585.09M. Total book value stands at 596.66M, with working capital of -331.93M providing operational flexibility.

Intermedical Care and Lab Hospital Public Company Limited NVDR produced 135.94M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -16.87M in capital expenditures, free cash flow totaled 119.07M - equivalent to 0.50 per share.

Over the twelve months ended June 30, 2026, Intermedical Care and Lab Hospital Public Company Limited NVDR posted a gross margin of 23.35, reflecting its pricing power and cost economics. The operating margin of 1.28 and net profit margin of -8.18 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Intermedical Care and Lab Hospital Public Company Limited NVDR paid dividends of - - per share. The dividend payout ratio of - - indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 16.53, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 17.18, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Intermedical Care and Lab Hospital Public Company Limited NVDR shareholders.

As of June 30, 2026, Intermedical Care and Lab Hospital Public Company Limited NVDR has an Altman Z-Score of 0.77, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.